厄洛替尼对比长春瑞滨联合顺铂辅助治疗ⅢA期EGFR突变阳性非小细胞肺癌患者的疗效
Efficacy of Erlotinib Versus Vinorelbine Plus Cisplatin as Adjuvant Therapy for StageⅢA EGFR Mutation-Positive Non-Small Cell Lung Cancer
厄洛替尼对比长春瑞滨联合顺铂辅助治疗ⅢA期EGFR突变阳性非小细胞肺癌患者的疗效 |
|
评价者：闫小龙 |
Efficacy of Erlotinib Versus Vinorelbine Plus Cisplatin as Adjuvant Therapy for StageⅢA EGFR Mutation-Positive Non-Small Cell Lung Cancer |
| |